![Kerem Kaya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Kerem Kaya is currently the Chief Financial Officer & Secretary at Medlab Clinical Ltd. since 2021.
Prior to this, he worked as a Manager-Global Finance Projects at Novartis AG.
Kerem Kaya active positions
| Companies | Position | Start |
|---|---|---|
| MEDB CLIN | Director of Finance/CFO | 13/05/2021 |
Former positions of Kerem Kaya
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Medlab Clinical Ltd.
 Medlab Clinical Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug development | Health Technology |
- Stock Market
- Insiders
- Kerem Kaya
